BAM
ABBV icon

Belpointe Asset Management’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.13M Sell
33,030
-1,595
-5% -$296K 0.26% 69
2025
Q1
$7.25M Sell
34,625
-4,903
-12% -$1.03M 0.38% 43
2024
Q4
$7.76M Sell
39,528
-242
-0.6% -$47.5K 0.47% 36
2024
Q3
$7.85M Buy
39,770
+2,062
+5% +$407K 0.47% 34
2024
Q2
$6.47M Buy
37,708
+1,010
+3% +$173K 0.45% 39
2024
Q1
$6.68M Buy
36,698
+2,148
+6% +$391K 0.5% 33
2023
Q4
$5.35M Buy
34,550
+403
+1% +$62.5K 0.47% 37
2023
Q3
$5.09M Buy
34,147
+971
+3% +$145K 0.53% 31
2023
Q2
$4.47M Sell
33,176
-25,476
-43% -$3.43M 0.47% 35
2023
Q1
$9.35M Sell
58,652
-2,366
-4% -$377K 0.5% 30
2022
Q4
$9.86M Buy
61,018
+4,807
+9% +$777K 0.6% 24
2022
Q3
$7.54M Buy
56,211
+10,423
+23% +$1.4M 0.51% 34
2022
Q2
$7.01M Sell
45,788
-9,900
-18% -$1.52M 0.47% 32
2022
Q1
$9.03M Sell
55,688
-11,610
-17% -$1.88M 0.55% 25
2021
Q4
$9.11M Buy
67,298
+1,474
+2% +$200K 0.57% 24
2021
Q3
$7.1M Buy
65,824
+12,164
+23% +$1.31M 0.48% 27
2021
Q2
$6.04M Buy
53,660
+2,642
+5% +$298K 0.44% 35
2021
Q1
$5.52M Sell
51,018
-6,547
-11% -$708K 0.47% 30
2020
Q4
$6.17M Buy
57,565
+3,145
+6% +$337K 0.55% 28
2020
Q3
$4.77M Sell
54,420
-8,829
-14% -$773K 0.53% 33
2020
Q2
$6.21M Buy
63,249
+31,762
+101% +$3.12M 0.8% 21
2020
Q1
$2.4M Sell
31,487
-1,848
-6% -$141K 0.42% 46
2019
Q4
$2.95M Buy
33,335
+5,991
+22% +$531K 0.37% 63
2019
Q3
$2.07M Buy
27,344
+3,589
+15% +$272K 0.34% 65
2019
Q2
$1.73M Sell
23,755
-597
-2% -$43.4K 0.34% 60
2019
Q1
$1.96M Buy
24,352
+103
+0.4% +$8.3K 0.38% 46
2018
Q4
$2.24M Buy
24,249
+4,342
+22% +$400K 0.57% 24
2018
Q3
$1.88M Sell
19,907
-943
-5% -$89.2K 0.3% 61
2018
Q2
$1.93M Sell
20,850
-1,248
-6% -$116K 0.54% 24
2018
Q1
$2.09M Sell
22,098
-7,702
-26% -$729K 0.61% 22
2017
Q4
$2.88M Buy
29,800
+5,503
+23% +$532K 0.63% 24
2017
Q3
$2.16M Buy
+24,297
New +$2.16M 0.51% 35